Pfizer Loses Marketing Exclusivity For Diflucan
The U.S. Food and Drug Administration has approved marketing applications from several generic drug makers to begin selling generic versions of Pfizer Inc.'s yeast infection treatment Diflucan....To view the full article, register now.
Already a subscriber? Click here to view full article